Proteomics and cancer diagnosis: the potential of mass spectrometry
- 1 July 2004
- journal article
- review article
- Published by Elsevier in Clinical Biochemistry
- Vol. 37 (7) , 579-583
- https://doi.org/10.1016/j.clinbiochem.2004.05.011
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- High Sequence Coverage of Proteins Isolated from Liquid Separations of Breast Cancer Cells Using Capillary Electrophoresis-Time-of-Flight MS and MALDI-TOF MS MappingAnalytical Chemistry, 2003
- The Vision for a New Diagnostic ParadigmClinical Chemistry, 2003
- Proteomic Patterns in Biological Fluids: Do They Represent the Future of Cancer Diagnostics?Clinical Chemistry, 2003
- Profiling the progression of cancer: Separation of microsomal proteins in MCF10 breast epithelial cell lines using nonporous chromatophoresisProteomics, 2003
- Multi‐component immunoaffinity subtraction chromatography: An innovative step towards a comprehensive survey of the human plasma proteomeProteomics, 2003
- Identification of distinct protein expression patterns in bilateral matched pair breast ductal fluid specimens from women with unilateral invasive breast carcinomaCancer, 2002
- The Human Plasma ProteomeMolecular & Cellular Proteomics, 2002
- PREOPERATIVE SERUM PROSTATE SPECIFIC ANTIGEN LEVELS BETWEEN 2 AND 22 NG./ML. CORRELATE POORLY WITH POST-RADICAL PROSTATECTOMY CANCER MORPHOLOGY: PROSTATE SPECIFIC ANTIGEN CURE RATES APPEAR CONSTANT BETWEEN 2 AND 9 NG./ML.Journal of Urology, 2002
- Proteinchip® surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixturesProstate Cancer and Prostatic Diseases, 1999
- New desorption strategies for the mass spectrometric analysis of macromoleculesRapid Communications in Mass Spectrometry, 1993